Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Cooley

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Leukemia & Lymphoma|January 7, 2016
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemiaDavid A Rizzieri, Sarah Cooley, Olatoyosi Odenike, et al.
American Journal of Hematology|June 22, 2012
Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignanciesBrenda J Weigel, Sarah Cooley, Todd DeFor, et al.
Cytotherapy|May 13, 2021
Infusion reactions in natural killer cell immunotherapy: a retrospective reviewTewodros Mamo, Shelly M Williams, Stephanie Kinney, et al.
Blood Advances|July 8, 2018
Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cellsHyun Don Yun, Martin Felices, Daniel A Vallera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 19, 2012
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigenBree Foley, Sarah Cooley, Michael R Verneris, et al.
Cancer Research|August 10, 2016
Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor CellsDhifaf Sarhan, Frank Cichocki, Bin Zhang, et al.
Blood Advances|August 21, 2019
The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samplesArmin Rashidi, Xianghua Luo, Sarah Cooley, et al.
Blood|March 15, 2013
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)Rizwan Romee, Bree Foley, Todd Lenvik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2010
Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockadeRobert Godal, Veronika Bachanova, Michelle Gleason, et al.
Blood Advances|March 21, 2019
Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLLMartin Felices, Behiye Kodal, Peter Hinderlie, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|January 7, 2016
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemiaDavid A Rizzieri, Sarah Cooley, Olatoyosi Odenike, et al.
American Journal of Hematology|June 22, 2012
Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignanciesBrenda J Weigel, Sarah Cooley, Todd DeFor, et al.
Cytotherapy|May 13, 2021
Infusion reactions in natural killer cell immunotherapy: a retrospective reviewTewodros Mamo, Shelly M Williams, Stephanie Kinney, et al.
Blood Advances|July 8, 2018
Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cellsHyun Don Yun, Martin Felices, Daniel A Vallera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 19, 2012
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigenBree Foley, Sarah Cooley, Michael R Verneris, et al.
Cancer Research|August 10, 2016
Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor CellsDhifaf Sarhan, Frank Cichocki, Bin Zhang, et al.
Blood Advances|August 21, 2019
The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samplesArmin Rashidi, Xianghua Luo, Sarah Cooley, et al.
Blood|March 15, 2013
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)Rizwan Romee, Bree Foley, Todd Lenvik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2010
Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockadeRobert Godal, Veronika Bachanova, Michelle Gleason, et al.
Blood Advances|March 21, 2019
Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLLMartin Felices, Behiye Kodal, Peter Hinderlie, et al.
Pageof 9